Citation Impact
Citing Papers
The endocannabinoid nervous system
2001
Korean Red Ginseng attenuates anxiety-like behavior during ethanol withdrawal in rats
2014
The effects of oxidative stress on female reproduction: a review
2012 Standout
Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats
2001
Behavioral Methods in Cannabinoid Research
2006
Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors
2002
The gastrointestinal pharmacology of cannabinoids: an update
2004
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
2009
Cannabinoid CB1‐receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
2001
Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats
2001
Conditioned Taste Aversion Induced by Ethanol in Alcohol-Preferring Rats
1999
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol
2002
Endocannabinoid system and alcohol addiction: Pharmacological studies
2005
The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats
2003
CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus
2007
Leptin-regulated endocannabinoids are involved in maintaining food intake
2001 Nature
Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats
2006
Central nervous system control of food intake and body weight
2006 StandoutNature
The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile
2004
N-acylethanolamines, anandamide and food intake
2009
Descending control of pain
2002 Standout
Vanilloid VR1receptor is involved in rimonabant‐induced neuroprotection
2006
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
2005
Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice
2003
Endocannabinoids as physiological regulators of colonic propulsion in mice
2002
Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors
2005
The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells
2003
Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?
2002
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
2010
ETHANOL INDUCES HIGHER BEC IN CB1 CANNABINOID RECEPTOR KNOCKOUT MICE WHILE DECREASING ETHANOL PREFERENCE
2004
Nonalcoholic Fatty Liver Disease: A Review and Update
2010
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
2019 Standout
Ethanol induces conditioned place preference in genetically selected alcohol-preferring rats
1999
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
2004
The gastrointestinal pharmacology of cannabinoids
2001
Endocannabinoids and the control of energy balance
2006
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
2003
Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew
2001
Fatty Acid Amide Hydrolase Controls Mouse Intestinal Motility In Vivo
2005
Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon
2002
The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
2004
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
The anandamide transport inhibitor AM404 activates vanilloid receptors
2000 StandoutNobel
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice
2003
Heavy Metal Tolerance in Plants: Role of Transcriptomics, Proteomics, Metabolomics, and Ionomics
2016 Standout
Review article: endocannabinoids and their receptors in the enteric nervous system
2005
Discriminative and Affective Stimulus Effects of Dihydropyridine Calcium Channel Modulators
1999
Molecular biology of cannabinoid receptors
2002
Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice
2004
Involvement of the endocannabinoid system in drug addiction
2006
GABAB Receptors: A New Paradigm in G Protein Signaling
2000
Gamma-hydroxybutyric acid An evaluation of its rewarding properties in rats and mice
2000
Comparison of novel cannabinoid partial agonists and SR141716A in the guinea‐pig small intestine
2000
Natural products for cancer chemotherapy
2010 Standout
Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems
2005
The cannabinoid system: a role in both the homeostatic and hedonic control of eating?
2003
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine
2002
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Inhibitory effects of SR141716A on G-protein activation in rat brain
2001
Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon
2004
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Panax ginseng and Panax quinquefolius: From pharmacology to toxicology
2017 Standout
Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals
2008
Emerging drugs to treat alcoholism
2010
Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference
2006
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Natural medicines for alcoholism treatment: a review
2005
Δ9-Tetrahydrocannabinol and Synthetic Cannabinoids Prevent Emesis Produced by the Cannabinoid CB1 Receptor Antagonist/Inverse Agonist SR 141716A
2001
Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist
1999
Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
2000
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats
2000
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat
1999
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Effects of chronic naltrexone treatment in rats on place preference and locomotor activation after acute administration of cocaethylene or ethanol plus cocaine
2004
A new lupene triterpenetriol and anticholinesterase activity of Salvia sclareoides
2007
Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium
2006
Repeated Administration of Gamma‐Hydroxybutyric Acid (GHB) to Mice
2002
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats
2003
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
2002
Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat
2004
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
2005
Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon
2006
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 Receptors
2004
Cannabis and the brain
2003
Localization of CB 1 -cannabinoid receptor immunoreactivity in the porcine enteric nervous system
2000
Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide
2004
Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors
1999
Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea‐pig ileum
2000
Milk thistle in liver diseases: past, present, future
2010 Standout
Endocannabinoid lipids and mediated system: Implications for alcoholism and neuropsychiatric disorders
2005
THE γ-HYDROXYBUTYRATE SIGNALLING SYSTEM IN BRAIN: ORGANIZATION AND FUNCTIONAL IMPLICATIONS
1997
Down-regulation of cannabinoid receptor agonist-stimulated [ ]GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouse
1999
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
2008 Standout
Cannabinoids and the Digestive Tract
2005
Identification of Miltirone as Active Ingredient of Salvia miltiorrhiza Responsible for the Reducing Effect of Root Extracts on Alcohol Intake in Rats
2006
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
2004
Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor
2003
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
The molecular logic of endocannabinoid signalling
2003 Standout
N-Acylethanolamines in human reproductive fluids
2002
Invited review: Body condition score and its association with dairy cow productivity, health, and welfare
2009 Standout
Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice
2006
Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system
2007
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
2002
Complementary therapies for treating alcoholism
2007
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
Do initial responses to drugs predict future use or abuse?
2012
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
2007 Standout
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
2004
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
2001
Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus
2002
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
2005
Energy Metabolism in the Liver
2014 Standout
Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide
2005
Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview
2002
Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats
2006
Synthetic and plant‐derived cannabinoid receptor antagonists show hypophagic properties in fasted and non‐fasted mice
2009
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
2003
Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
2002
Transient Receptor Potential Cation Channels in Disease
2007 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
2000
Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development
2000
Endocannabinoids in the regulation of appetite and body weight
2005
Plants and the central nervous system
2003 Standout
Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study
2003
Cannabinoids and the gut: New developments and emerging concepts
2010
Endocannabinoids and the gut
2002
Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice
2003
Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol‐seeking behavior in rats
2005
Effect of nociceptin on alcohol intake in alcohol-preferring rats
1999
The cannabinoid receptor antagonist SR�141716 attenuates overfeeding induced by systemic or intracranial morphine
2003
Neuropharmacology and therapeutic potential of cannabinoids
2000
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
GABA in plants: just a metabolite?
2004 Standout
Cannabinoids mediate opposing effects on inflammation‐induced intestinal permeability
2011
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
2003 Standout
Therapeutic Potential of Cannabinoids in CNS Disease
2003
Endocannabinoid control of food intake and energy balance
2005
Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology
2001
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Constituents from Salvia Species and Their Biological Activities
2012 Standout
The British Journal of Nutrition, an international journal that continues to develop
2006 Standout
Endogenous cannabinoids and appetite.
2001
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
2005
Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol
2002
Synthesis, structure and properties of polyhydroxyalkanoates: biological polyesters
2000 Standout
The Taxane Diterpenoids
1999
Pharmacological Approaches for the Treatment of Obesity
2002
Cardiovascular effects of Danshen
2007 Standout
Rimonabant for overweight or obesity
2006
Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats
2009
A Critical Role for the Cannabinoid CB1Receptors in Alcohol Dependence and Stress-Stimulated Ethanol Drinking
2003
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Effects of SR141716A on Ethanol and Sucrose Self‐Administration
2001
Gamma‐Hydroxybutyric Acid (GHB) in the Treatment of Alcohol Withdrawal Syndrome: A Randomized Comparative Study Versus Benzodiazepine
1999
Genetics of behaviour: phenotypic and molecular study of rats derived from high- and low-alcohol consuming lines.
2003
Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats
2005
Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-Administration
2001
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
2003
Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens
2003
Mechanisms of Sound Localization in Mammals
2010 Standout
Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice
2003
Cannabinoids and the gastrointestinal tract
2001
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding
2002
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Effects of SR141716A on Ethanol and Sucrose Self-Administration
2001
Genetic Architecture of Tameness in a Rat Model of Animal Domestication
2009 StandoutNobel
Comparison of Antioxidant Activities of Isoflavones from Kudzu Root ( Pueraria lobata Ohwi)
2003
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
2005
Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing
2005
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia
2006
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
2002
Endogenous cannabinoids and appetite
2001
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Genetics of behaviour
2003
Identification of the role of endogenous cannabinoids in pain modulation: strategies and pitfalls
2000
Endocannabinoids and Food Intake: Newborn Suckling and Appetite Regulation in Adulthood
2005
Works of Roberta Reali being referenced
Involvement of the cannabinoid receptor in the intestinal propulsion in mice
1998
CIRCADIAN DRINKING PATTERN OF SARDINIAN ALCOHOL-PREFERRING RATS
1996
Potential use of medicinal plants in the treatment of alcoholism
2000
Sardinian alcohol-preferring rats prefer chocolate and sucrose over ethanol
1997
Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: Occurrence within narrow dose ranges
1995
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract
2003
γ-Hydroxybutyric Acid Intake in Ethanol-preferring sP and -nonpreferring sNP Rats
1998
-HYDROXYBUTYRIC ACID REDUCING EFFECT ON ETHANOL INTAKE: EVIDENCE IN FAVOUR OF A SUBSTITUTION MECHANISM
1998
Cross-tolerance to ethanol and γ-hydroxybutyric acid
1995
Oral self-administration of γ-hydroxybutyric acid in the rat
1995
CONSTANT ABSOLUTE ETHANOL INTAKE BY SARDINIAN ALCOHOL-PREFERRING RATS INDEPENDENT OF ETHANOL CONCENTRATIONS
1997
Cannabinoid modulation of intestinal propulsion in mice
1998
Blockade of ethanol discrimination by isradipine
1994
Alcohol stimulates motor activity in selectively bred Sardinian alcohol-preferring (sP), but not in Sardinian alcohol-nonpreferring (sNP), rats
2001
Development of short-lasting alcohol deprivation effect in Sardinian alcohol-preferring rats
2000
Blockade of the discriminative stimulus effects of γ-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382
1995
Stimulation of locomotor activity by voluntarily consumed ethanol in Sardinian alcohol-preferring rats
1998
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
1998
REDUCTION OF VOLUNTARY ETHANOL INTAKE IN ETHANOL-PREFERRING sP RATS BY THE CANNABINOID ANTAGONIST SR-141716
1998
Relationship between Cannabinoid CB<SUB>1</SUB> and Dopamine D<SUB>2</SUB> Receptors in Intestinal Motility in Mice
2000
Different Sensitivity to Ethanol in Alcohol‐Preferring sP and ‐Nonpreferring sNP Rats
2000
Dissociation of Ethanol and Saccharin Preference in sP and sNP rats
2000